MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,690 | -56.5% | 268,506 | +10.4% | 0.00% | – |
| Q2 2023 | $364,896 | +52.1% | 243,264 | +74.4% | 0.00% | – |
| Q1 2023 | $239,926 | +191.5% | 139,492 | +94.9% | 0.00% | – |
| Q4 2022 | $82,301 | -57.4% | 71,566 | -3.4% | 0.00% | – |
| Q3 2022 | $193,000 | +319.6% | 74,085 | +249.1% | 0.00% | – |
| Q2 2022 | $46,000 | -92.1% | 21,219 | -83.0% | 0.00% | – |
| Q1 2022 | $583,000 | -78.8% | 125,145 | -72.5% | 0.00% | – |
| Q4 2021 | $2,756,000 | +913.2% | 455,068 | +1106.8% | 0.00% | – |
| Q3 2021 | $272,000 | +216.3% | 37,709 | +175.2% | 0.00% | – |
| Q2 2021 | $86,000 | – | 13,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |